首页> 外文期刊>Quality engineering >Studying Unidentified Impurities in Drug Substances by the Application of Multivariate (Principal Component and Cluster) Analysis
【24h】

Studying Unidentified Impurities in Drug Substances by the Application of Multivariate (Principal Component and Cluster) Analysis

机译:应用多元(主成分和聚类)分析研究药物中的不确定杂质

获取原文
获取原文并翻译 | 示例
           

摘要

One of the most important quality characteristics of a drug substance is its impurity profile, which is defined as a description of the identified and unidentified impurities in a drug substance. The impurity profile very often constitutes an identifier of a particular drug substance and its associated method of manufacture. It is always desirable to determine the chemical structure of any unidentified impurity, since this very often suggests the origin and ways of controlling impurities during the manufacturing process. Unfortunately, however, this is not always economically and technically feasible. In this article, the application of multivariate analysis (principal component and hierarchical cluster analysis) is illustrated through a case study carried out in a bulk chemical plant, where the main goal was the detection of potential underlying structures in the relationships among the impurities making up the impurity profile of a drug substance. These underlying structures in turn might suggest hypotheses about the origin of unidentified impurities.
机译:原料药最重要的质量特征之一是其杂质分布,其定义是对原料药中已识别和未识别杂质的描述。杂质分布通常构成特定药物及其相关制造方法的标识符。确定任何未鉴定出的杂质的化学结构始终是可取的,因为这经常表明制造过程中杂质的来源和控制方法。然而,不幸的是,这在经济和技术上并不总是可行的。在本文中,通过在一家大型化工厂中进行的案例研究,说明了多元分析(主要成分和层次聚类分析)的应用,其主要目标是检测构成杂质的关系中潜在的潜在结构。原料药的杂质分布。这些潜在的结构反过来可能提出有关未识别杂质来源的假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号